Get the Stockscreener App
1.41
4.08%
-0.06
Pre-market:
1.41
China Sxt Pharmaceuticals Inc stock is traded at $1.41, with a volume of 13,236.
It is down -4.08% in the last 24 hours and down -37.61% over the past month.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
See More
Previous Close:
$1.47
Open:
$1.39
24h Volume:
13,236
Relative Volume:
0.05
Market Cap:
$1.20M
Revenue:
$1.54M
Net Income/Loss:
$-8.87M
P/E Ratio:
-0.0397
EPS:
-35.4915
Net Cash Flow:
$-2.74M
1W Performance:
-21.67%
1M Performance:
-37.61%
6M Performance:
-99.40%
1Y Performance:
-99.67%
1-Day Range:
$1.39
$1.476
1-Week Range:
$1.3856
$1.8788
52-Week Range:
$1.3856
$1,046.98
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Compare SXTC vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
1.41 | 1.20M | 1.54M | -8.87M | -2.74M | -35.49 |
TAK
Takeda Pharmaceutical Co Adr
|
18.04 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.93 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.14 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
531.82 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
China Sxt Pharmaceuticals Inc Stock (SXTC) Latest News
China SXT Pharmaceuticals implements dual-class share structure - Investing.com
China SXT Pharmaceuticals, Inc. Announces Share Re-classification - Yahoo Finance
SXTC Should I Buy - Intellectia AI
China SXT Pharmaceuticals, Inc. (SXTC) - MSN
Trading Recap: Whats the analyst consensus on China SXT Pharmaceuticals Inc2026 Risk Factors & Daily Market Momentum Tracking - baoquankhu1.vn
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Down 29.1% in February - Defense World
This nano-cap pharma stock crashed 30% today – what triggered the sell-off? - MSN
SXTCChina Sxt Pharmaceuticals Inc Latest Stock News & Market Updates - Stock Titan
Can China SXT Pharmaceuticals Inc. (2RY) stock attract ESG investments2026 Technicals & Reliable Entry Point Alerts - Naître et grandir
This Nano-cap Pharma Stock Crashed 30% Today – What Triggered The Sell-off? - Stocktwits
SXTC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CEO Moves: Can China SXT Pharmaceuticals Inc beat the S P 5002025 Price Targets & High Win Rate Trade Alerts - baoquankhu1.vn
Chinese Stocks To Watch TodayMarch 1st - MarketBeat
SXTC PE Ratio & Valuation, Is SXTC Overvalued - Intellectia AI
Is China SXT Pharmaceuticals Inc trading at a discountMarket Sentiment Report & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Declines By 99.0% - Defense World
Best Chinese Stocks To Follow TodayFebruary 26th - MarketBeat
Is China SXT Pharmaceuticals Inc. stock gaining market shareJuly 2025 Intraday Action & Technical Pattern Alert System - mfd.ru
China SXT Pharmaceuticals Inc (SXTC) - MSN
SXTC Technical Analysis & Stock Price Forecast - Intellectia AI
Top Chinese Stocks To Consider – February 10th - Defense World
EV Market: Will Airship AI Holdings Inc benefit from geopolitical trends2025 Analyst Calls & Risk Managed Investment Entry Signals - baoquankhu1.vn
Best Chinese Stocks Worth Watching – February 9th - Defense World
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Top Chinese Stocks To ConsiderFebruary 10th - MarketBeat
EBIT of China Sxt Pharmaceuticals, Inc. – TRADEGATE:2RY1 - TradingView
China SXT Pharmaceuticals Announces Reverse Stock Split - StocksToTrade
Best Chinese Stocks Worth WatchingFebruary 9th - MarketBeat
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
China SXT Pharma Launches AI Supply Chain Overhaul for TCMs - timothysykes.com
Best Chinese Stocks To Watch Today – February 7th - Defense World
Best Chinese Stocks To Watch TodayFebruary 7th - MarketBeat
Wall Street Zen Upgrades China SXT Pharmaceuticals (NASDAQ:SXTC) to Sell - Defense World
Operating margin % of China Sxt Pharmaceuticals, Inc. – GETTEX:A41YPR - TradingView
Debt to equity ratio of China Sxt Pharmaceuticals, Inc. – GETTEX:A41YPR - TradingView
Operating expenses (excl. COGS) of China Sxt Pharmaceuticals, Inc. – GETTEX:A41YPR - TradingView
China SXT Pharmaceuticals (NASDAQ:SXTC) Hits New 1-Year LowHere's What Happened - MarketBeat
Short Squeeze: Will China SXT Pharmaceuticals Inc outperform its industry peersWeekly Trend Recap & Verified Momentum Stock Watchlist - baoquankhu1.vn
China SXT Pharmaceuticals (NASDAQ:SXTC) Shares Gap DownHere's What Happened - MarketBeat
+39% after hours Most Active: SXTC China SXT Pharm NASDAQ 02/02/26: watch float - Meyka
Chinese Stocks To Watch Now – February 1st - Defense World
Here’s Why China SXT Pharmaceuticals Stock (SXTC) Rocketed Today - TipRanks
Why DarkIris Shares Are Trading Higher By Over 100%; Here Are 20 Stocks Moving Premarket - Benzinga
Promising Chinese Stocks To Follow Today – January 31st - Defense World
China SXT Pharmaceuticals To Carry Out 1-for-150 Reverse Stock Split On February 3rd, 2026 - 富途牛牛
Chinese Stocks To Watch NowFebruary 1st - MarketBeat
China SXT Pharmaceuticals to consolidate shares 1-for-150 - MSN
Promising Chinese Stocks To Follow TodayJanuary 31st - MarketBeat
Chinese Stocks To Keep An Eye On – January 29th - Defense World
Chinese Stocks Worth WatchingJanuary 30th - MarketBeat
Penny Stocks To Add to Your WatchlistJanuary 8th - MarketBeat
China Sxt Pharmaceuticals Inc Stock (SXTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):